Evidence map›Paper›PMID 39601966›Full record

ArticleJournal of community genetics2025

Motivations, perceptions and impacts of direct-to-consumer genetic testing among users in Brazil.

Larissa Siqueira Penna, Raphael Bruno Amemiya, Thiago Pires, Larissa Sousa Silva Bonasser, Leonardo Carvalheira, Cintia Fridman, Regina Celia Mingroni-Netto, Michel Satya Naslavsky, Ricardo di Lazzaro Filho

Abstract read
In one paragraph

Article in Journal of community genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Larissa Siqueira Penna *Genera/Dasa Genômica, São Paulo, SP, Brazil.ORCID http://orcid.org/0009-0003-4175-7202
Raphael Bruno Amemiya *Genera/Dasa Genômica, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0001-9326-0765
Thiago PiresCentro de Estudos sobre o Genoma Humano e Células Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0009-0005-5670-3244
Larissa Sousa Silva BonasserGenera/Dasa Genômica, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-7812-8026
Leonardo CarvalheiraCentro de Estudos sobre o Genoma Humano e Células Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0009-0001-8602-987X
Cintia FridmanDepartamento de Medicina Legal, Bioética, Medicina do Trabalho e Medicina Física e Reabilitação, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-2430-4888
Regina Celia Mingroni-NettoCentro de Estudos sobre o Genoma Humano e Células Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0001-9233-5227
Michel Satya NaslavskyCentro de Estudos sobre o Genoma Humano e Células Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-9068-1713
Ricardo di Lazzaro FilhoGenera/Dasa Genômica, São Paulo, SP, Brazil. ricardo.filho@dasa.com.br.ORCID http://orcid.org/0000-0002-8987-5246

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous studies have focused on direct-to-consumer genetic testing (DTC-GT), but little is known about consumers outside North America and Europe. Therefore, this study assesses the sociodemographic profile, motivations, and impacts of DTC-GT among Brazilian consumers. DTC-GT customers were invited to complete a 30-question online survey anonymously. Descriptive statistics and Chi-Square tests were used to analyze the data, with significant findings analyzed using post-hoc and correspondence analysis. This study comprised 1513 Brazilian DTC-GT consumers with a mean age of 42 years old and mostly female (60.8%). Participants' primary motivation for purchasing the test was to learn about their genetic predispositions to diseases (87.2%) followed by biogeographical ancestry (86.2%). Fewer than 20% of respondents reported consulting a healthcare professional due to the test results (18.4%), and most consumers felt confident in independently understanding the test results (66.9%), which was significantly associated with Health/Biological Sciences professional field (p < 0.001). Additionally, many customers felt glad (63.3%), and few felt worried after receiving their results (13.4%), particularly concerning health outcomes. Lifestyle changes included dietary adjustments (38.7%), regular health check-ups (24.2%) and increased physical activity (16.5%). Overall, 64.0% of respondents reported altering habits following test results. These findings contribute to understanding the motivations and impacts of DTC-GT among Brazilian consumers, indicating positive lifestyle changes and limited negative psychological impacts.

Indexed as

Consumer perceptionsDirect-to-consumer genetic testingHealth impactsLifestyle impactsPersonal genomics

Identifiers

PMID39601966
PMCPMC12321725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.